How the body processes fish oil and other supplements
This study compares how healthy adults absorb fish oil (CreNeuroS CNS Fish Oil Plus) with two approved medicines (Vascepa and Deplin). It helps researchers understand if the new product works similarly in the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old.
- Your body mass index (BMI) is between 18.5 and 25, and you weigh at least 110 pounds (50 kg).
- You are in good health, with normal heart, chest, and lab tests.
- You are a non-smoker or a moderate smoker (no more than 10 cigarettes a day).
- You do not have high blood pressure or a history of serious medical conditions.
- If you are a woman able to have children, you agree to use birth control or are surgically sterile.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how a fish oil and folate supplement is absorbed in healthy people. It helps understand how the body processes the supplement, which could inform future use.
This study compares two different formulations of omega-3 supplements (EPA and DHA) to see how well the body absorbs them. You will be a healthy participant, and the results will help determine if one form is better than the other.
This study looks at how your genes and sex affect the way your body uses EPA, a key fat found in fish oil. If you are healthy and not currently eating fish or taking fish oil supplements, you may help researchers learn why people respond differently to omega-3s.
This trial tests whether adding a special fish oil supplement (CreNeuroS) to the antidepressant escitalopram helps improve depression symptoms more than escitalopram alone. If you have moderate to severe depression and are starting or recently started escitalopram, this study may help you find a more effective treatment.
This study tests whether a prescription fish-oil medicine called icosapent ethyl can improve heart health by reducing plaques (fatty deposits) in the arteries, lowering inflammation, and helping the heart remodel (recover) after a heart event. It is designed for people with heart disease and high triglycerides.
This study tests whether a purified fish oil medicine called icosapent ethyl (IPE), taken along with your usual statin, can further lower the risk of heart attacks and strokes in people who already have heart or blood vessel disease. It aims to reduce the leftover risk even after standard cholesterol treatment.
Hear when a new Bioavailability trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.